Lawek Berzenji

University of Antwerp, Antwerp University Hospital

Papers

4

Total Citations

28

H-Index

3

About

Lawek Berzenji is a leading thoracic surgeon whose research centers on the evolution of minimally invasive surgery for thoracic malignancies, particularly non-small cell lung cancer (NSCLC) and thymic epithelial tumors. His work critically evaluates the transition from conventional video-assisted thoracoscopic surgery (VATS) to robotic-assisted thoracoscopic surgery (RATS), highlighting how robotic systems overcome the limitations of traditional MIS by offering superior 3D optics and enhanced instrument dexterity. Berzenji’s most influential paper, "Minimally Invasive Surgery in Non-Small Cell Lung Cancer: Where Do We Stand?" (2023, 10 citations), provides a comprehensive assessment of the current landscape, while his 2020 study on robotic lobectomy (9 citations) further establishes the clinical advantages of this approach. His narrative review on thymic epithelial tumors (2024, 7 citations) addresses the surgical management of these rare neoplasms, underscoring the importance of resectability. With a growing citation record and contributions that directly inform surgical practice, Berzenji is shaping the future of thoracic oncology by demonstrating how robotic technology can improve patient outcomes, shorten hospital stays, and enhance quality of life.

Research Focus

Key Achievements

3
H-Index
4
Papers
28
Total Citations
7
Avg Citations/Paper
🏆 Most Cited Paper
Minimally Invasive Surgery in Non-Small Cell Lung Cancer: Where Do We Stand?
10 citations · 2023
📈 Most Prolific Year: 2020 (2 Papers)
🤝 Key Collaborators: 13
🏛 Institutions: University of Antwerp, Antwerp University Hospital

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 15 days ago